ArticleFrontiers in oncology2024

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.

Magdalena Knetki-Wróblewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.